Boron Nitride Nanotube as an Antimicrobial Peptide Carrier: A Theoretical Insight

Cited 0 time in webofscience Cited 0 time in scopus
  • Hit : 29
  • Download : 0
Introduction: Nanotube-based drug delivery systems have received considerable attention because of their large internal volume to encapsulate the drug and the ability to penetrate tissues, cells, and bacteria. In this regard, understanding the interaction between the drug and the nanotube to evaluate the encapsulation behavior of the drug in the nanotube is of crucial importance. Methods: In this work, the encapsulation process of the cationic antimicrobial peptide named cRW3 in the biocompatible boron nitride nanotube (BNNT) was investigated under the Canonical ensemble (NVT) by molecular dynamics (MD) simulation. Results: The peptide was absorbed into the BNNT by van der Waals (vdW) interaction between cRW3 and the BNNT, in which the vdW interaction decreased during the simulation process and reached the value of -142.7 kcal.mol(-1) at 4 ns. Discussion: The increase in the potential mean force profile of the encapsulated peptide during the pulling process of cRW3 out of the nanotube showed that its insertion into the BNNT occurred spontaneously and that the inserted peptide had the desired stability. The energy barrier at the entrance of the BNNT caused a pause of 0.45 ns when half of the peptide was inside the BNNT during the encapsulation process. Therefore, during this period, the peptide experienced the weakest movement and the smallest conformational changes.
Publisher
DOVE MEDICAL PRESS LTD
Issue Date
2021-03
Language
English
Article Type
Article
Citation

INTERNATIONAL JOURNAL OF NANOMEDICINE, v.16, pp.1837 - 1847

ISSN
1176-9114
DOI
10.2147/IJN.S298699
URI
http://hdl.handle.net/10203/282197
Appears in Collection
RIMS Journal Papers
Files in This Item
There are no files associated with this item.

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0